Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q2 2022 · 10-Q
Revenue$11.99M$11.99M— vs Q2 2021 Net Income$21.67M$21.67M−44.7% vs Q2 2021 EPS Diluted$0.47$0.47−44.7% vs Q2 2021 Operating Cash Flowderived$56,768,000+10.0% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 8, 2022 · 39 d after period end